Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Latest Breaking News
In reply to the discussion: Scorpion sting leaves Arizona woman with huge bill [View all]Posteritatis
(18,807 posts)34. Almost certainly both.
A lot of pharmaceutical companies will sell medication in poorer or more developing countries at prices which are high locally but still (mostly) affordable; the nature of those companies means they wouldn't be doing that if they couldn't turn a profit from it. Well, maybe exceptions for something media-friendly like HIV medication, but antivenin is pretty mundane by comparison.
Ridiculous hospital markups go without saying, of course. Don't three or four digit charges for tylenol happen there now and then?
Edit history
Please sign in to view edit histories.
Recommendations
0 members have recommended this reply (displayed in chronological order):
44 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
RecommendedHighlight replies with 5 or more recommendations
Not sure about hospitals in Mexico, but in the United States, hospitals exist to make a profit.
Selatius
Sep 2012
#2
Apparently, the market can bear a lot when your respiratory system is failing.
Hassin Bin Sober
Sep 2012
#25
I wonder what the bill would have been if she were uninsured? I'm guessing less.
bad sofa king
Sep 2012
#3
It could have been MUCH worse. Look at what a scorpion sting did to this poor little dog...
slackmaster
Sep 2012
#14
Damn, someone needs to warn that woman to keep her distance from R Pie Hole!
lonestarnot
Sep 2012
#17
If Mexico's charging $100 that implies something about the scale of the markup. (nt)
Posteritatis
Sep 2012
#31